Stuart Kupfer
Directeur Technique/Scientifique/R&D chez CYTOKINETICS, INCORPORATED
Profil
Stuart Kupfer is currently the Chief Medical Officer & Senior Vice President at Cytokinetics, Inc. Prior to his current position, he worked as the Vice President & Head-Therapeutic Area at Takeda Pharmaceuticals U.S.A., Inc. from 2004 to 2016.
He also has a doctorate degree from the University of Florida.
Postes actifs de Stuart Kupfer
Sociétés | Poste | Début |
---|---|---|
CYTOKINETICS, INCORPORATED | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Anciens postes connus de Stuart Kupfer
Sociétés | Poste | Fin |
---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/01/2016 |
Formation de Stuart Kupfer
University of Florida | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CYTOKINETICS, INCORPORATED | Health Technology |
Entreprise privées | 1 |
---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |